Jessica Lo1, Leighton Chan2, Spencer Flynn1. 1. Rehabilitation Medicine Department, National Institutes of Health, Bethesda, MD. 2. Rehabilitation Medicine Department, National Institutes of Health, Bethesda, MD. Electronic address: chanle@cc.nih.gov.
Abstract
OBJECTIVES: To present recent evidence on the prevalence, incidence, costs, activity limitations, and work limitations of common conditions requiring rehabilitation. DATA SOURCES: Medline (PubMed), SCOPUS, Web of Science, and the gray literature were searched for relevant articles about amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury. STUDY SELECTION: Relevant articles (N=106) were included. DATA EXTRACTION: Two investigators independently reviewed articles and selected relevant articles for inclusion. Quality grading was performed using the Methodological Evaluation of Observational Research Checklist and Newcastle-Ottawa Quality Assessment Form. DATA SYNTHESIS: The prevalence of back pain in the past 3 months was 33.9% among community-dwelling adults, and patients with back pain contribute $365 billion in all-cause medical costs. Osteoarthritis is the next most prevalent condition (approximately 10.4%), and patients with this condition contribute $460 billion in all-cause medical costs. These 2 conditions are the most prevalent and costly (medically) of the illnesses explored in this study. Stroke follows these conditions in both prevalence (2.5%-3.7%) and medical costs ($28 billion). Other conditions may have a lower prevalence but are associated with relatively higher per capita effects. CONCLUSIONS: Consistent with previous findings, back pain and osteoarthritis are the most prevalent conditions with high aggregate medical costs. By contrast, other conditions have a lower prevalence or cost but relatively higher per capita costs and effects on activity and work. The data are extremely heterogeneous, which makes anything beyond broad comparisons challenging. Additional information is needed to determine the relative impact of each condition. Published by Elsevier Inc.
OBJECTIVES: To present recent evidence on the prevalence, incidence, costs, activity limitations, and work limitations of common conditions requiring rehabilitation. DATA SOURCES: Medline (PubMed), SCOPUS, Web of Science, and the gray literature were searched for relevant articles about amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury. STUDY SELECTION: Relevant articles (N=106) were included. DATA EXTRACTION: Two investigators independently reviewed articles and selected relevant articles for inclusion. Quality grading was performed using the Methodological Evaluation of Observational Research Checklist and Newcastle-Ottawa Quality Assessment Form. DATA SYNTHESIS: The prevalence of back pain in the past 3 months was 33.9% among community-dwelling adults, and patients with back pain contribute $365 billion in all-cause medical costs. Osteoarthritis is the next most prevalent condition (approximately 10.4%), and patients with this condition contribute $460 billion in all-cause medical costs. These 2 conditions are the most prevalent and costly (medically) of the illnesses explored in this study. Stroke follows these conditions in both prevalence (2.5%-3.7%) and medical costs ($28 billion). Other conditions may have a lower prevalence but are associated with relatively higher per capita effects. CONCLUSIONS: Consistent with previous findings, back pain and osteoarthritis are the most prevalent conditions with high aggregate medical costs. By contrast, other conditions have a lower prevalence or cost but relatively higher per capita costs and effects on activity and work. The data are extremely heterogeneous, which makes anything beyond broad comparisons challenging. Additional information is needed to determine the relative impact of each condition. Published by Elsevier Inc.
Authors: J J Deeks; J Dinnes; R D'Amico; A J Sowden; C Sakarovitch; F Song; M Petticrew; D G Altman Journal: Health Technol Assess Date: 2003 Impact factor: 4.014
Authors: Jasmina I Ivanova; Howard G Birnbaum; Matt Schiller; Evan Kantor; Bryan M Johnstone; Ralph W Swindle Journal: Spine J Date: 2011-05-20 Impact factor: 4.166
Authors: Anthony O Asemota; A Karim Ahmed; Taylor E Purvis; Peter G Passias; C Rory Goodwin; Daniel M Sciubba Journal: World Neurosurg Date: 2018-08-02 Impact factor: 2.104
Authors: Lynn M Marshall; Stephanie Litwack-Harrison; Una E Makris; Deborah M Kado; Peggy M Cawthon; Richard A Deyo; Nels L Carlson; Michael C Nevitt Journal: J Gerontol A Biol Sci Med Sci Date: 2017-09-01 Impact factor: 6.053
Authors: Yejin Lee; Ryan J Walsh; Mandy W M Fong; Marek Sykora; Michelle M Doering; Alex W K Wong Journal: Neurosci Biobehav Rev Date: 2021-10-06 Impact factor: 8.989
Authors: Carmen Navarrete; Adela García-Martín; Alejandro Correa-Sáez; María E Prados; Francisco Fernández; Rafael Pineda; Massimiliano Mazzone; Marina Álvarez-Benito; Marco A Calzado; Eduardo Muñoz Journal: J Neuroinflammation Date: 2022-07-09 Impact factor: 9.587